TURNER TIMOTHY WILLIAM

CEO Timothy Turner sold 129.6K RYAN shares (91.2% of holdings) at $53.61 for $6.9M on 2025-12-12

CEO Timothy Turner executed a substantial sale of 129.6K shares at $53.61, reducing his holdings from 142.1K to 12.6K shares—a 91.2% reduction in his stake. The sale occurred at a price $0.58 below the current market price of $54.19, and at a significant discount to the 52-week high of $75.93. His single prior sale at RYAN on 2024-08-09 occurred at a time when the stock subsequently gained 13.9% over 90 days, indicating the prior sale was poorly timed from a hindsight perspective. The magnitude and near-complete divestiture of his position warrants investor attention, as it represents a material shift in his ownership concentration, though the absence of scheduled trade flags in this record limits the degree to which timing can be characterized as deliberate strategic action.

RYAN President TURNER TIMOTHY WILLIAM sold 2,000,000 shares at $62.45 on 2024-08-09 for $124,900,000, retaining 8,095 shares via derivative conversion.

President TURNER TIMOTHY WILLIAM executed a substantial sale of 2,000,000 shares valued at $124,900,000 at $62.45 per share on 2024-08-09, reducing his direct equity stake from 2,008,095 to 8,095 shares. The filing flags a derivative-conversion transaction, indicating his principal economic position resides in converted securities (Table II) not yet populated in this database, so his post-transaction holdings extend beyond the 8,095 shares reported in Table I. This sale occurred when RYAN stock trades at $65.09 current price, +15.9% over the prior 30 days and +21.2% over 90 days, reflecting upward momentum from the sale date. The company's trailing metrics show strong revenue growth (+20.4% year-over-year), though elevated P/E of 87.96 and $7.2B market cap reflect a growth-weighted valuation typical for specialty insurance platforms with RYAN's recent consolidation trajectory.